Movement Disorders

>

The NeurologyLive® movement disorders clinical focus page is a source for all the latest news regarding the clinical care of patients with Parkinson disease, essential tremor, Huntington disease, dystonia, ataxia, and more. This page features podcasts, videos, and news about FDA actions, study and clinical trial findings, clinical guideline updates, and interviews with experts in the clinical care of movement disorders.

Latest News

NeurologyLive® Year in Review 2024: Top Conference Coverage Stories
NeurologyLive® Year in Review 2024: Top Conference Coverage Stories

December 26th 2024

As part of NeurologyLive®'s Year in Review, we've compiled the top coverage stories from 2024 across a variety of different neurological conferences the team either attended or covered virtually.

NeurologyLive® Year in Review 2024: Most-Read Features
NeurologyLive® Year in Review 2024: Most-Read Features

December 24th 2024

Jonathan R. Isaacson, MD  (Credit: LinkedIn)
Syn-One Test Displays Significant Clinical Utility for the Diagnosis of Synucleinopathies

December 22nd 2024

Parkinson Agent Prasinezumab Misses Primary End Point But Shows Positive Effects in Other Outcomes
Parkinson Agent Prasinezumab Misses Primary End Point But Shows Positive Effects in Other Outcomes

December 20th 2024

Walid Abi-Saab, MD  (Credit: uniQure)
FDA Reaches Alignment on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington Disease

December 12th 2024

Latest CME Events & Activities

Burst Expert Illustrations & Commentary™ : Visualizing the Role of the Complement Proteins in Neurologic Disorders

View More

Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients

View More

Burst Expert Illustrations & Commentary™: Visualizing the Implications of Anti-Complement Therapies on Generalized Myasthenia Gravis

View More

Burst Expert Illustrations & Commentary™: Visualizing the Role of the Complement Pathway in Neurological Disorders

View More

Little Voices, Big Challenges: Comprehensive Care for Pediatric Spinal Muscular Atrophy

January 9, 2025

Register Now!

Individualizing Treatment for Patients with Generalized Myasthenia Gravis

View More

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

March 1, 2025

Register Now!

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Clinical ShowCase™ in ALS: Addressing Diagnostic Delays, Evolving Therapies, and Multidisciplinary Care

View More

Burst Expert Illustrations & Commentary™: Visualizing the Role of FcRN in Neurological Disorders

View More

BURST Expert Illustrations and Commentaries™: Visualizing FcRn as a Therapeutic Target in Neurological Disease

View More

BURST Expert Illustrations and Commentaries™: Visualizing the Implications of FcRN-Targeted Therapies on Generalized Myasthenia Gravis

View More

Clinical Consultations™: Navigating the Evolving Treatment Landscape in Generalized Myasthenia Gravis

View More

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

View More

Burst Expert Illustrations & Commentary™: Visualizing the Role of Subcutaneous Infusion as an Alternate Administration Route for Medical Interventions

View More

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

View More

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

View More

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

View More

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

View More

Carolina Neuromuscular Disease Summit

September 27, 2025

Register Now!

SimulatEd™ From Discomfort to Relief: Acute Pain Management Essentials

View More

Evolving Perspectives in Alzheimer's Disease: Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances

View More

Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

View More

Medical Crossfire®: Integrating Real-World Data to Improve Outcomes for Patients With Multiple Sclerosis

View More

Medical Crossfire® - Optimizing Management for Patients With Generalized Myasthenia Gravis: Focus on Complement Inhibitors

View More

Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents

View More

Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine

View More

Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings

View More

Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine

View More

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

View More

© 2024 MJH Life Sciences

All rights reserved.